Your browser doesn't support javascript.

Portal de Pesquisa da BVS

Informação e Conhecimento para a Saúde

Home > Pesquisa > ()
XML
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Molecular Epidemiology of Neisseria meningitidis Serogroup B in Brazil

Filippis, Ivano de; Lemos, Ana Paula S. de; Hostetler, Jessica B; Wollenberg, Kurt; Sacchi, Claudio T; Harrison, Lee H; Bash, Margaret C; Prevots, Rebecca.
Plos one ; 7(3): e33016, 2012. graf
Artigo em Inglês | SES-SP, LILACS, SESSP-CTDPROD, SES-SP | ID: biblio-1052243

Background:

Neisseria meningitidis serogroup B has been predominant in Brazil, but no broadly effective vaccine is available to prevent endemic meningococcal disease. To understand genetic diversity among serogroup B strains in Brazil, we selected a nationally representative sample of clinical disease isolates from 2004, and a temporally representative sample for the state of Sa˜o Paulo (1988­2006) for study (n = 372).

Methods:

We performed multi-locus sequence typing (MLST) and sequence analysis of five outer membrane protein (OMP) genes, including novel vaccine targets fHbp and nadA.

Results:

In 2004, strain B4P1.15,19 clonal complex ST-32/ET-5 (cc32) predominated throughout Brazil; regional variation in MLST sequence type (ST), fetA, and porB was significant but diversity was limited for nadA and fHbp. Between 1988 and 1996, the Sa˜o Paulo isolates shifted from clonal complex ST-41/44/Lineage 3 (cc41/44) to cc32. OMP variation was associated with but not predicted by cc or ST. Overall, fHbp variant 1/subfamily B was present in 80% of isolates and showed little diversity. The majority of nadA were similar to reference allele 1.

Conclusions:

A predominant serogroup B lineage has circulated in Brazil for over a decade with significant regional and temporal diversity in ST, fetA, and porB, but not in nadA and fHbp.
Biblioteca responsável: BR91.2
Localização: BR91.2